400 related articles for article (PubMed ID: 31775598)
1. Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of Autophagy.
Spirina LV; Avgustinovich AV; Afanas'ev SG; Cheremisina OV; Volkov MY; Choynzonov EL; Gorbunov AK; Usynin EA
Curr Drug Targets; 2020; 21(7):713-721. PubMed ID: 31775598
[TBL] [Abstract][Full Text] [Related]
2. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
3. miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.
An Y; Zhang Z; Shang Y; Jiang X; Dong J; Yu P; Nie Y; Zhao Q
Cell Death Dis; 2015 May; 6(5):e1766. PubMed ID: 25996293
[TBL] [Abstract][Full Text] [Related]
4. Mapping the Pathways of Resistance to Targeted Therapies.
Wood KC
Cancer Res; 2015 Oct; 75(20):4247-51. PubMed ID: 26392071
[TBL] [Abstract][Full Text] [Related]
5. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
[TBL] [Abstract][Full Text] [Related]
6. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
[TBL] [Abstract][Full Text] [Related]
7. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells.
Russi S; Verma HK; Laurino S; Mazzone P; Storto G; Nardelli A; Zoppoli P; Calice G; La Rocca F; Sgambato A; Lucci V; Falco G; Ruggieri V
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370155
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/CXCR4 axis by regulating autophagy in gastric cancer.
Tang H; Long Q; Zhuang K; Han K; Zhang X; Guo H; Lu X
Pathol Res Pract; 2021 Aug; 224():153532. PubMed ID: 34214844
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
10. Autophagy Facilitates Metadherin-Induced Chemotherapy Resistance Through the AMPK/ATG5 Pathway in Gastric Cancer.
Pei G; Luo M; Ni X; Wu J; Wang S; Ma Y; Yu J
Cell Physiol Biochem; 2018; 46(2):847-859. PubMed ID: 29635244
[TBL] [Abstract][Full Text] [Related]
11. CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer.
Xu W; Wei Q; Han M; Zhou B; Wang H; Zhang J; Wang Q; Sun J; Feng L; Wang S; Ye Y; Wang X; Zhou J; Jin H
Int J Biol Sci; 2018; 14(9):1054-1066. PubMed ID: 29989092
[TBL] [Abstract][Full Text] [Related]
12. Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway.
Wang B; Guan G; Zhao D
Biomed Pharmacother; 2020 May; 125():109961. PubMed ID: 32028241
[TBL] [Abstract][Full Text] [Related]
13. Autophagy and multidrug resistance in cancer.
Li YJ; Lei YH; Yao N; Wang CR; Hu N; Ye WC; Zhang DM; Chen ZS
Chin J Cancer; 2017 Jun; 36(1):52. PubMed ID: 28646911
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
15. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
Lu C; Shan Z; Li C; Yang L
Biomed Pharmacother; 2017 Feb; 86():450-456. PubMed ID: 28012924
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells.
Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Hu H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819864311. PubMed ID: 31405336
[TBL] [Abstract][Full Text] [Related]
17. miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1.
Huang H; Tang J; Zhang L; Bu Y; Zhang X
Int J Oncol; 2018 Dec; 53(6):2769-2779. PubMed ID: 30320370
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer.
Lei Y; Tang L; Hu J; Wang S; Liu Y; Yang M; Zhang J; Tang B
Biomed Pharmacother; 2020 May; 125():109896. PubMed ID: 32007918
[TBL] [Abstract][Full Text] [Related]
20. WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells.
Yuan G; Regel I; Lian F; Friedrich T; Hitkova I; Hofheinz RD; Ströbel P; Langer R; Keller G; Röcken C; Zimmermann W; Schmid RM; Ebert MP; Burgermeister E
Oncogene; 2013 Jan; 32(3):375-87. PubMed ID: 22370641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]